Is this the end of the road for daily islatravir 0·75 mg?

Lancet HIV. 2024 Jun;11(6):e346-e347. doi: 10.1016/S2352-3018(24)00120-6. Epub 2024 May 8.

Authors

Jennifer Hoy¹, James McMahon²

Affiliations

¹ Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, VIC 3004, Australia. Electronic address: jennifer.hoy@monash.edu.
² Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, VIC 3004, Australia; Department of Infectious Diseases, Monash Health, Melbourne, VIC, Australia.

PMID: 38734014
DOI: 10.1016/S2352-3018(24)00120-6

No abstract available

MeSH terms

Anti-HIV Agents / administration & dosage
Anti-HIV Agents / therapeutic use
HIV Infections* / drug therapy
Humans

Substances

Anti-HIV Agents